# ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease

> **NCT07718659** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 8 (estimated)

## Conditions studied

- Parkinson's Disease (PD)
- Parkinsonian Disorders

## Interventions

- **GENETIC:** ZR001

## Key facts

- **NCT ID:** NCT07718659
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718659, "ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07718659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*